CD47 IHC signal was comparable between primary treatment-naïve and FOLFOX-treated patients, implying FOLFOX per se does not affect CD47 expression in CRC tumors, however, significantly higher CD47 staining was detected in liver metastases (Figure 1F). This evidence concerns the gene CD47 and colorectal carcinoma.